Use of ileal bile acid transporter inhibitors in children with genetic familial cholestasis and Alagille syndrome: the why, when and how

Siddharth Mahesh, Chayarani Kelgeri

Open source

DOI
10.1136/archdischild-2025-328955
Published
2026-02-24
Container
Archives of disease in childhood - Education & practice edition
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/archdischild-2025-328955,
  title = {Use of ileal bile acid transporter inhibitors in children with genetic familial cholestasis and Alagille syndrome: the why, when and how},
  author = {Siddharth Mahesh and Chayarani Kelgeri},
  year = {2026},
  journal = {Archives of disease in childhood - Education \& practice edition},
  doi = {10.1136/archdischild-2025-328955},
  url = {https://doi.org/10.1136/archdischild-2025-328955}
}

RIS

TY  - JOUR
TI  - Use of ileal bile acid transporter inhibitors in children with genetic familial cholestasis and Alagille syndrome: the why, when and how
AU  - Siddharth Mahesh
AU  - Chayarani Kelgeri
PY  - 2026
JO  - Archives of disease in childhood - Education & practice edition
DO  - 10.1136/archdischild-2025-328955
UR  - https://doi.org/10.1136/archdischild-2025-328955
ER  - 

APA

Mahesh, S., & Kelgeri, C. (2026). Use of ileal bile acid transporter inhibitors in children with genetic familial cholestasis and Alagille syndrome: the why, when and how. Archives of disease in childhood - Education & practice edition. https://doi.org/10.1136/archdischild-2025-328955

Source records